Waly Dioh Ph.D. serves as Chief Operating Officer of the Company.D serves as Chief Operating Officer of the Company. serves as Chief Operating Officer of the Company. Dr. Dioh joined Biophytis at the inception in 2006 and managed Biophytis’ clinical trials as VP Clinical Development before being promoted to the COO position. As COO he will drive all aspects of pharmaceutical, regulatory preclinical and early clinical operations. Prior to joining Biophytis, Waly was at Monsanto, in France and the U.S. where he ran a regulatory affairs team for the development of biotechnology products. He has a PhD in Biology from Paris XI University.

With a doctorate in phytopathology (Paris XI), Waly Dioh spent most of his career with R&D teams in Monsanto, initially in France to set up a genotyping platform and then in the United States (Saint Louis – Missouri) where he ran a regulatory affairs team for the development of biotechnology products. He joined Biophytis at the inception and manages current clinical trials.